Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Doroshow, James H."'
Autor:
Koc S; Seven Bridges, Charlestown, MA 02129, USA., Lloyd MW; The Jackson Laboratory, Bar Harbor, ME 04609, USA., Grover JW; Seven Bridges, Charlestown, MA 02129, USA., Xiao N; Seven Bridges, Charlestown, MA 02129, USA., Seepo S; Seven Bridges, Charlestown, MA 02129, USA., Subramanian SL; Seven Bridges, Charlestown, MA 02129, USA., Ray M; Seven Bridges, Charlestown, MA 02129, USA., Frech C; Seven Bridges, Charlestown, MA 02129, USA., DiGiovanna J; Seven Bridges, Charlestown, MA 02129, USA., Webster P; Seven Bridges, Charlestown, MA 02129, USA., Neuhauser S; The Jackson Laboratory, Bar Harbor, ME 04609, USA., Srivastava A; The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA., Woo XY; The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA., Sanderson BJ; The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA., White B; The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA., Lott P; University of California - Davis, Davis, CA 95616, USA., Dobrolecki LE; Baylor College of Medicine, Houston, TX 77030, USA., Dowst H; Baylor College of Medicine, Houston, TX 77030, USA., Evrard YA; Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA., Wallace TA; Center to Reduce Health Disparities, National Cancer Institute, Bethesda, MD 20814, USA., Moscow JA; Investigational Drug Branch, National Cancer Institute, Bethesda, MD 20814, USA., Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20814, USA., Mitsiades N; Baylor College of Medicine, Houston, TX 77030, USA., Kaochar S; Baylor College of Medicine, Houston, TX 77030, USA., Pan CX; University of California - Davis, Davis, CA 95616, USA., Chen MS; University of California - Davis, Davis, CA 95616, USA., Carvajal-Carmona L; University of California - Davis, Davis, CA 95616, USA., Welm AL; Huntsman Cancer Institute, Salt Lake City, UT 84112, USA., Welm BE; Huntsman Cancer Institute, Salt Lake City, UT 84112, USA., Lewis MT; Baylor College of Medicine, Houston, TX 77030, USA., Govindan R; Washington University School of Medicine, St. Louis, MO 63110, USA., Ding L; Washington University School of Medicine, St. Louis, MO 63110, USA., Li S; Washington University School of Medicine, St. Louis, MO 63110, USA., Herlyn M; The Wistar Institute, Philadelphia, PA 19104, USA., Davies MA; The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Roth J; The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Meric-Bernstam F; The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Robinson PN; The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA., Bult CJ; The Jackson Laboratory, Bar Harbor, ME 04609, USA., Davis-Dusenbery B; Seven Bridges, Charlestown, MA 02129, USA., Dean DA 2nd; Seven Bridges, Charlestown, MA 02129, USA., Chuang JH; The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA.
Publikováno v:
NAR cancer [NAR Cancer] 2022 Apr 22; Vol. 4 (2), pp. zcac014. Date of Electronic Publication: 2022 Apr 22 (Print Publication: 2022).
Autor:
Zhang P; UC Berkeley College of Letters and Science, Berkeley, CA 94720, USA., Palmisano A; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD 20850, USA.; General Dynamics Information Technology (GDIT), Falls Church, VA 22042, USA., Kumar R; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD 20850, USA., Li MC; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD 20850, USA., Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD 20850, USA.; Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA., Zhao Y; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD 20850, USA.
Publikováno v:
Bioinformatics (Oxford, England) [Bioinformatics] 2022 Jan 03; Vol. 38 (2), pp. 570-572.
Autor:
Doroshow JH; Division of Cancer Treatment and Diagnosis and Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Prindiville S; Coordinating Center for Clinical Trials, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., McCaskill-Stevens W; Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Mooney M; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA., Loehrer PJ; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Oct 01; Vol. 113 (10), pp. 1281-1284.
A Phase I Study of Ganetespib and Ziv-Aflibercept in Patients with Advanced Carcinomas and Sarcomas.
Autor:
Meehan R; Early Clinical Trials Development Program, Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA., Kummar S; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA., Do K; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA., O'Sullivan Coyne G; Early Clinical Trials Development Program, Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA., Juwara L; Clinical Research Directorate/Clinical Monitoring Research Program, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland, USA., Zlott J; Early Clinical Trials Development Program, Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA., Rubinstein L; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA., Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA., Chen AP; Early Clinical Trials Development Program, Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA chenali@mail.nih.gov.
Publikováno v:
The oncologist [Oncologist] 2018 Nov; Vol. 23 (11), pp. 1269-e125. Date of Electronic Publication: 2018 May 31.
Autor:
Kummar S; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (SK, ECP, APC, LVR, YZ, RMS, BAC, JHD); Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD (PMW, CJL). kummars@mail.nih.gov., Williams PM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (SK, ECP, APC, LVR, YZ, RMS, BAC, JHD); Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD (PMW, CJL)., Lih CJ; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (SK, ECP, APC, LVR, YZ, RMS, BAC, JHD); Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD (PMW, CJL)., Polley EC; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (SK, ECP, APC, LVR, YZ, RMS, BAC, JHD); Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD (PMW, CJL)., Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (SK, ECP, APC, LVR, YZ, RMS, BAC, JHD); Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD (PMW, CJL)., Rubinstein LV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (SK, ECP, APC, LVR, YZ, RMS, BAC, JHD); Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD (PMW, CJL)., Zhao Y; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (SK, ECP, APC, LVR, YZ, RMS, BAC, JHD); Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD (PMW, CJL)., Simon RM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (SK, ECP, APC, LVR, YZ, RMS, BAC, JHD); Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD (PMW, CJL)., Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (SK, ECP, APC, LVR, YZ, RMS, BAC, JHD); Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD (PMW, CJL)., Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (SK, ECP, APC, LVR, YZ, RMS, BAC, JHD); Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD (PMW, CJL).
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2015 Feb 06; Vol. 107 (4). Date of Electronic Publication: 2015 Feb 06 (Print Publication: 2015).
Autor:
Abrams JS; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD 20852, USA. abramsj@mail.nih.gov, Mooney MM, Zwiebel JA, Korn EL, Friedman SH, Finnigan SR, Schettino PR, Denicoff AM, Kruhm MG, Montello M, Misra RR, Ansher SS, DiPiazza KJ, Souhan EM, Wickerham DL, Giantonio BJ, O'Donnell RT, Sullivan DM, Soto NI, Fleming GF, Prindiville SA, Petryshyn RA, Hautala JA, Grad O, Zuckerman BL, Meyer RM, Yao JC, Baker LA, Buckner JC, Hortobagyi GN, Doroshow JH
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2013 Jul 03; Vol. 105 (13), pp. 954-9. Date of Electronic Publication: 2013 Jun 17.
Autor:
Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland 20892, USA. doroshoj@mail.nih.gov, Sleijfer S, Stupp R, Anderson K
Publikováno v:
The oncologist [Oncologist] 2013 Jun; Vol. 18 (6), pp. 651-2.
Autor:
Humphrey RW; Global Development, Bristol-Myers Squibb Company, Princeton, NJ, USA., Brockway-Lunardi LM, Bonk DT, Dohoney KM, Doroshow JH, Meech SJ, Ratain MJ, Topalian SL, Pardoll DM
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2011 Aug 17; Vol. 103 (16), pp. 1222-6. Date of Electronic Publication: 2011 Jul 15.
Autor:
Zhang YW; Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD 20892, USA., Regairaz M, Seiler JA, Agama KK, Doroshow JH, Pommier Y
Publikováno v:
Nucleic acids research [Nucleic Acids Res] 2011 May; Vol. 39 (9), pp. 3607-20. Date of Electronic Publication: 2011 Jan 11.
Autor:
Freedman AN; National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-7393, USA. andrew_freedman@nih.gov, Sansbury LB, Figg WD, Potosky AL, Weiss Smith SR, Khoury MJ, Nelson SA, Weinshilboum RM, Ratain MJ, McLeod HL, Epstein RS, Ginsburg GS, Schilsky RL, Liu G, Flockhart DA, Ulrich CM, Davis RL, Lesko LJ, Zineh I, Randhawa G, Ambrosone CB, Relling MV, Rothman N, Xie H, Spitz MR, Ballard-Barbash R, Doroshow JH, Minasian LM
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2010 Nov 17; Vol. 102 (22), pp. 1698-705. Date of Electronic Publication: 2010 Oct 13.